Andrew R. Robbins, COO at ARRAY BIOPHARMA INC (ARRY), sold 288,968 shares at $10.72 ($3.1M) on 2017-12-18, disclosed to the SEC on 2017-12-19.
Open-market sale of $3.1M ARRY by COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.92 | 6,094 | $67K | 2.1% |
| 2 | $10.72 | 282,874 | $3.0M | 97.9% |
| Total | $10.72 avg | 288,968 | $3.1M | 100% |
| Filing → |